da17b8969c15ad1a70104ce891f9d141 *DESCRIPTION
edcfb3b29d3fc74d838d6268d1df41be *INDEX
1d1b14bd9637dd9cdbd5cbc0fdf17815 *Meta/Rd.rds
12ed0e180b77883de01755a3d466994c *Meta/data.rds
50a9fa3e1aa2c47fa7bdbd6e6bb8974e *Meta/features.rds
2da60dbb3c4d50f9f8cf51ee85b54e5d *Meta/hsearch.rds
1bd19fb09e9fed100c577ac3fa11217e *Meta/links.rds
676ec0720d54c3e317bf9cde6dee7294 *Meta/nsInfo.rds
6d603d244e3cbea6e4dde68e0855405a *Meta/package.rds
fc57446bbb333a615ec848b787509839 *Meta/vignette.rds
96e2d5b61cbea0ffcebdc747d37dfb54 *NAMESPACE
776df24ebe89888b153a1b621b7d291d *NEWS.md
d6c68f1fe41ced6e98a766a3757313da *R/nlmixr2lib
bf2b3a8664ab1676a5d02cc88f3bd29e *R/nlmixr2lib.rdb
faacd0322f290e77c2038bd1a971e605 *R/nlmixr2lib.rdx
95d272fdb3e09d011961e698543d18b8 *README.md
375d977493c5a511cb0c8509a0b32c8b *WORDLIST
be3de267f13fe78bd878507c09cb9df0 *data/Rdata.rdb
dd060df40092612de86cd91abf2b1959 *data/Rdata.rds
f87535e54dfcfd72165e828a87e116b3 *data/Rdata.rdx
22c0e4c6dc6f666bbdee552141c45e62 *doc/Grimm_2023.R
a0d6acb0c43827d12b6dc694db070116 *doc/Grimm_2023.Rmd
82d1dfeabd10f4a2c126383b66853f30 *doc/Grimm_2023.html
554c4fc60421d9e9c68963b61997c75e *doc/Kyhl_2016_nalmefene.R
6fceccee18a669ed3aeb2b7efebc432d *doc/Kyhl_2016_nalmefene.Rmd
dfbd0b8aa3ebca6893eafca0bfc8223c *doc/Kyhl_2016_nalmefene.html
3c3b76d609cb9beb87fb7447b8587409 *doc/Xie_2019_agomelatine.R
a9566cda5aefb8f030d313365cece17c *doc/Xie_2019_agomelatine.Rmd
190ff78b56423a04014c6708e960037c *doc/Xie_2019_agomelatine.html
43f6f19aba9e9c0d70d5012c95a6aa49 *doc/create-model-library.R
5c6f8bca5ff453cc64525d72a335847a *doc/create-model-library.Rmd
ea54fd08c04dcb4292ea8b7bbc981cec *doc/create-model-library.html
fcaf56b92b8c7576d2d6e73010affb1f *doc/index.html
2c73584e59f642379a6a8dba2cc7166f *doc/list-of-models.R
77378800a842961d6b7fdbf28e5ffbb4 *doc/list-of-models.Rmd
cd66986f29eb32212f6dbd38001b57ef *doc/list-of-models.html
958659ded8617d9ca247d86d0793ae0c *help/AnIndex
7b6c267aa1f451df98f7a765b07d45fd *help/aliases.rds
b9b9c44411b5d19d5f6012436f0aa0bb *help/nlmixr2lib.rdb
b32518d516f139df879126ddbc95bf87 *help/nlmixr2lib.rdx
0206d0ada6c2eb3753764a1345f1fada *help/paths.rds
bf242c3804459ad7c3972afc4aee5f1d *html/00Index.html
ee41876c0116916bb04bcf4fe3e43d78 *html/R.css
1cbb0e38e117b2ef822bc298a3114c3d *modeldb.qs2
61ca926eeeb90647a0421efd712173ed *modeldb/PK_1cmt.R
cff5a39e92a41b890c1bd5f5f7137266 *modeldb/PK_1cmt_des.R
b899d29dfceeff90ca56d46df2240768 *modeldb/PK_2cmt.R
68fe5e47bb99ccf9f3cbe0c2d7026b0b *modeldb/PK_2cmt_des.R
61c8f79ddf758a74625d19e4e2bee562 *modeldb/PK_2cmt_no_depot.R
105a95586da5ba90638086f4897b2412 *modeldb/PK_2cmt_tdcl_des.R
5690eebedf2056e5e3d12cfab567b777 *modeldb/PK_3cmt.R
4197f3a53244febc119ca9a1c72fae21 *modeldb/PK_3cmt_des.R
886559d3a4306c457080acff43df1615 *modeldb/endogenous/igg_kim_2006.R
b836983d132daad6b39a0feedb95d88c *modeldb/endogenous/phenylalanine_charbonneau_2021.R
2bd88171e99e5506c12bf4dd8fddbd86 *modeldb/pharmacodynamics/indirect_0cpt_transitEx.R
134b54b3c5994d4685314334323fa1b3 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin.R
b55383102241b9935776139b7360c3d7 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin_CLV.R
93f00eda2e48ca6791094f640af05fc2 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin_r0rmaxcrmax.R
8faab6b392c04b364decfc13b90162a7 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout.R
177d3b40267c06ce88cf223be78a0b55 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout_CLV.R
165d0c172b2256815ad13938355800f5 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout_r0rmaxcrmax.R
77feda9627d66fd0317b07dc2665b88e *modeldb/pharmacodynamics/indirect_1cpt_stim_kin.R
1e8d008acaf0d0e49afabbe6c4668a5b *modeldb/pharmacodynamics/indirect_1cpt_stim_kin_CLV.R
cd8bf22d5916027411ecb609dfaa996c *modeldb/pharmacodynamics/indirect_1cpt_stim_kin_r0rmaxcrmax.R
f00dd551d303f12392e27145bfa0bc51 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout.R
d6104ced55a4434d14729f934f01c236 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout_CLV.R
9e0fff4209e2a00007bfa707728227f7 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout_r0rmaxcrmax.R
67adacd1e0c57386f644abf2db37e824 *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kin_kin_t.R
205baa47c64ddb0d5d5c4522bcd00fad *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kin_kout_t.R
aceae429788a0f3b7cf58ad0763ed280 *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kout_kin_t.R
67d1441532c7f6ed03113f3c0c658d9d *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kout_kout_t.R
f144a7251ec899077e4167459e6c1652 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kin_kin_t.R
4fb9401a90e57e118a9439e1313b09c6 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kin_kout_t.R
ff9e7104740411080d00ae3038dfc069 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kout_kin_t.R
da277f5b947e4bc23868a868e0e82e21 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kout_kout_t.R
6f0829e30011e0ea50e6087206408fee *modeldb/pharmacodynamics/indirect_prec_1cpt_inhi_CLV.R
6aed6b218636fb4afbcf1ff86974d596 *modeldb/pharmacodynamics/indirect_prec_1cpt_inhi_r0rmaxcrmax.R
272367adcda60dd566f3b81ab9d24bf1 *modeldb/pharmacodynamics/indirect_prec_1cpt_stim_CLV.R
1afe99281f7afc7af9edea0694c15e4c *modeldb/pharmacodynamics/indirect_prec_1cpt_stim_r0rmaxcrmax.R
9c5c473a2b7bff1129fff46bdc4f0220 *modeldb/pharmacokinetics/PK_2cmt_mAb_Davda_2014.R
22828c8d0c0ad4fdfb5e3225dbfeebe6 *modeldb/pharmacokinetics/PK_double_sim_01.R
55f78184c9ec5517b7ad83821b6b1194 *modeldb/pharmacokinetics/PK_double_sim_10.R
ab65cb2a68468877361e01bba51dba91 *modeldb/pharmacokinetics/PK_double_sim_11.R
adcc43f3a4f88a8d76e7bfa57273d604 *modeldb/specificDrugs/CarlssonPetri_2021_liraglutide.R
ed8d76ce1b0a06990cefd1fa2b97a900 *modeldb/specificDrugs/Cirincione_2017_exenatide.R
4ef199765fbd9be5fe7a8aea735c8e0b *modeldb/specificDrugs/Grimm_2023_gantenerumab.R
1c0a0f3b5db4d113d199cc74ef3a29db *modeldb/specificDrugs/Grimm_2023_trontinemab.R
33076601badb4e52e5039e178c061e87 *modeldb/specificDrugs/Kovalenko_2020_dupilumab.R
12878edf52288767c481a87db71a7185 *modeldb/specificDrugs/Kyhl_2016_nalmefene.R
9777378994c57f1e2dc2294ddeb34fea *modeldb/specificDrugs/Soehoel_2022_tralokinumab.R
bb38f2628ccef59598df4b36178bceab *modeldb/specificDrugs/Xie_2019_agomelatine.R
33283dbae268619b149385e69ee037d8 *modeldb/specificDrugs/Zhu_2017_lebrikizumab.R
714a044237110ec04d85c5ea52c76303 *modeldb/therapeuticArea/oncology/oncology_sdm_lobo_2002.R
fb8f7ff43debc576fbdfd52b88c2f9ec *modeldb/therapeuticArea/oncology/oncology_xenograft_simeoni_2004.R
15039d27cb0b75bd19ac2c00d89589b8 *modeldb/therapeuticArea/oncology/tgi_no_sat_Koch.R
9b002b4e89d3a73cab6965625fdf98f0 *modeldb/therapeuticArea/oncology/tgi_no_sat_expo.R
dd340d07d5f3163e6a58d0ca2ba057f4 *modeldb/therapeuticArea/oncology/tgi_no_sat_linear.R
d7065a2d34a919b3dd742d8625359e91 *modeldb/therapeuticArea/oncology/tgi_no_sat_powerLaw.R
97fa51d4e6d185654ebbf1865490a405 *modeldb/therapeuticArea/oncology/tgi_sat_Gompertz.R
c82e583e771c63ac4e480352cf13e829 *modeldb/therapeuticArea/oncology/tgi_sat_VonBertalanffy.R
8a1d3c7d397f8e38219a548110fe3236 *modeldb/therapeuticArea/oncology/tgi_sat_genLogistic.R
e8c613c4be05327adeb3d4cb05da0276 *modeldb/therapeuticArea/oncology/tgi_sat_genVonBertalanffy.R
579c47e1fe80bb17680ebde6b3dc92b3 *modeldb/therapeuticArea/oncology/tgi_sat_logistic.R
